Share:
Peer-Reviewed Publication
Malar J2015;14526.December 30, 2015Evaluation Study

Computer-vision-based technology for fast, accurate and cost effective diagnosis of malaria.

Bina Srivastava1, Anupkumar R Anvikar2, Susanta K Ghosh3, Neelima Mishra4, Navin Kumar5, Arnon Houri-Yafin6, Joseph Joel Pollak7, Seth J Salpeter8, Neena Valecha9
1National Institute of Malaria Research, Sector 8 Dwarka, New Delhi, 110 077, India. shbira@gmail.com.
2National Institute of Malaria Research, Sector 8 Dwarka, New Delhi, 110 077, India. anvikar@rediffmail.com.
3National Institute of Malaria Research Field Unit, Bengaluru, India. ghoshnimr@gmail.com.
4National Institute of Malaria Research, Sector 8 Dwarka, New Delhi, 110 077, India. neelima.nimr@gmail.com.
5National Institute of Malaria Research, Sector 8 Dwarka, New Delhi, 110 077, India. navinjh@gmail.com.
6Sight Diagnostics, 1 Agudat Hasport Hapoel, Jerusalem Technology Park, Jerusalem, Israel. arnon@sightdx.com.
7Sight Diagnostics, 1 Agudat Hasport Hapoel, Jerusalem Technology Park, Jerusalem, Israel. yossi@sightdx.com.
8Sight Diagnostics, 1 Agudat Hasport Hapoel, Jerusalem Technology Park, Jerusalem, Israel. seth@sightdx.com.
9National Institute of Malaria Research, Sector 8 Dwarka, New Delhi, 110 077, India. neenavalecha@gmail.com.

Abstract

BACKGROUND: Microscopy has long been considered to be the gold standard for diagnosis of malaria despite the introduction of newer assays. However, it has many challenges like requirement of trained microscopists and logistic issues. A vision based device that can diagnose malaria, provide speciation and estimate parasitaemia was evaluated. METHODS: The device was evaluated using samples from 431…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.